Post by
SironaInvestor on Dec 14, 2022 1:20pm
Bexacat is on the market - and Sirona again too late
https://www.reuters.com/business/healthcare-pharmaceuticals/fda-approves-first-oral-treatment-cats-with-type-diabetes-2022-12-08/
Guys, this announcement again is a testament of all the missing timelines from Sirona in the past. Promoting to be very close to announce a step changing deal for pet diabetes and competition just signed a wonderful deal!!
Amazing stuff, Elanco!! Our treatment will come soon to the market, probably with the name SiroCat !! :-)
Comment by
Turtle4 on Dec 14, 2022 1:50pm
Other pharma companies dont even wait after Christmas Holidays? Interesting...
Comment by
str8goods4achg on Dec 14, 2022 2:22pm
Good find and iinteresting! I hope our molecule doesn't have the same risk profile as Bexacat. Not sure I'd want to give it to my cat. Maybe this will help accelerate negotiations??
Comment by
forhandlaren on Dec 14, 2022 5:05pm
Elanco where in talks with Sirona, maybe they prioritized being early on the market over safety. Safety is one if the most valuable properties that Sirona always claims, so there is a good chance that our compound is better.
Comment by
MirrorWorldMan on Dec 14, 2022 9:56pm
Its an SGLT2 with an initial phase 1 study done by Wannabang who had proprietarized the data. Safety data is nonexistent with WannabangSironaflozin. My guess is Howie lost the pet deal, hard to say when he has become a mute.
Comment by
SleepyHoward on Dec 15, 2022 7:52am
Where was the problem 2 years ago when the great ceo told us we will see tge petdeal soon. Soon is now more than 2 years and we still waiting for a deal. How can we trust a ceo like him?
Comment by
navajojoe on Dec 15, 2022 8:57am
This post has been removed in accordance with Community Policy